Showing results (51-60 of 78) with videos related to
Sort By:
Pageof 8
Frontiers in Cellular and Infection Microbiology|March 16, 2019
<i>Pseudomonas aeruginosa Exoprotein</i>-Induced Barrier Disruption Correlates With Elastase Activity and Marks Chronic Rhinosinusitis SeverityJian Li, Mahnaz Ramezanpour, Stephanie A Fong, et al.Microbiology Spectrum|March 31, 2025
Genomic variation in <i>Pseudomonas aeruginosa</i> clinical respiratory isolates with <i>de</i> <i>novo</i> resistance to a bacteriophage cocktailStephanie A Fong, George Bouras, Ghais Houtak, et al.Diseases of the Colon and Rectum|September 27, 2007
Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusalL Lim, M Chao, J Shapiro, et al.Foods (Basel, Switzerland)|February 26, 2025
Pulsed Electric Field Treatment of Sweet Potatoes to Reduce Oil and Acrylamide in Kettle ChipsMark M Skinner, Morgan A Fong, Tauras P Rimkus, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2009
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancerM D Green, P A Francis, V Gebski, et al.Frontiers in Cellular and Infection Microbiology|October 12, 2017
Activity of Bacteriophages in Removing Biofilms of <i>Pseudomonas aeruginosa</i> Isolates from Chronic Rhinosinusitis PatientsStephanie A Fong, Amanda Drilling, Sandra Morales, et al.Science (New York, N.Y.)|August 25, 2001
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathwayU Senftleben, Y Cao, G Xiao, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|January 8, 2019
Safety and efficacy of a bacteriophage cocktail in an in vivo model of Pseudomonas aeruginosa sinusitisStephanie A Fong, Amanda J Drilling, Mian Li Ooi, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 17, 2001
Efficacy and safety of orally/sublingually, intranasally, and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virusG Sonnenfeld, M Tovey, H Schellekens, et al.Vox Sanguinis|April 12, 2022
A new high-prevalence LW antigen detected by an antibody in an Indigenous Australian homozygous for LW*A c.309C>A variantGenghis H Lopez, Brett Wilson, Glenda M Millard, et al.Pageof 8